tirzepatide 30mg vial Tirzepatide | Research Peptide |

The MHRA approved tirzepatide following clinical trials demonstrating superior glycaemic control and weight loss compared to other GLP-1 receptor agonists

Behavioural support , including referral to NHS weight management services or a dietitian, may be appropriate for patients who are struggling

Always keep communication open with your healthcare team, and never hesitate to report new or worsening symptoms

& Aarabi, M

They are the most likely to cause discomfort and the least likely to deliver the protein your body needs most after a fast

61 Medullary thyroid cancer There is a theoretical increased risk of medullary thyroid cancer (MTC) as preclinical studies showed a link between GLP-1 receptor agonism to the development of C-cell hyperplasia and MTC in rodents